In support of this notion are studies showing decreased serum/plasma PON-1 activity in neurological disorders associated with increased oxidative stress and/or neuroinflammation such as autism (61), multiple sclerosis (62), and dementia (63). The gene discussed is PON1; the disease is nervous system disorder.